Finance

A collection of 311 posts

Paid-members only

Finance Featured

Can Bessent Cap the Long Bond Without the Fed?

The Treasury doubled its long-bond buybacks to stop a selloff — and the rally lasted 48 hours. What the failed intervention reveals about who actually controls the long end, and what Warsh's Jackson Hole debut now has to decide.

Finance Featured

Why Costco Is Walking Into the Market Health Insurers Are Fleeing

UnitedHealth, Humana, and Aetna are cutting Medicare Advantage by the hundreds of counties. Costco just entered the $500 billion market — with a deal structured so the retailer can't lose.

Finance Featured

Three Industries Are Paying for the Most Expensive Midterms in History

The all-time record for corporate election spending fell in March — seven months before a single midterm vote. The money isn't coming from oil, pharma, or banks: crypto, AI, and sportsbooks are buying the regulatory map.

Paid-members only

Markets Featured

Who Sells Poland When It Stops Being Emerging?

S&P Dow Jones just handed Poland the decade's first promotion out of emerging markets. The reward: losing its biggest required buyers. Inside the graduation trade — the flows timeline, the MSCI catalyst, and the names that benefit.

Paid-members only

Finance Featured

The Hackers Picking Off Private Equity One Phone Call at a Time

Hackers just walked out of a $938 billion asset manager with a phone call and a fake login page. The targeting shift behind the Apollo breach reprices operational risk for private equity — and hands the mandate to a short list of identity-security names.

Paid-members only

Investing Featured

$LUNR: Intuitive Machines Hit a $1.8B Backlog. Now the Hard Math Starts.

Intuitive Machines quadrupled Q2 revenue to $206M and landed a $600M satellite deal. With 27% of the float short and $481M in debt, the bull case depends on math the stream hasn't done.

Paid-members only

Investing Featured

$MRNA: Moderna Just Made History Twice. Now the Market Has to Decide What It's Worth.

In two weeks, Moderna got the first mRNA flu vaccine approved in U.S. history and won the first successful Phase 3 for a personalized cancer vaccine. The stock moved 177% in a day. Here's what it's worth.

Paid-members only

Finance Featured

The Best Bonds of 2026 Bet That Inflation Never Left

The Global Agg has lost money this year. Broad EM local debt returned 1.5%. One $886 billion corner of the bond market returned 11.3% — by assuming inflation would stay. How the trade worked, and where the money is rotating next.

Markets Featured

American Drug Prices Just Broke a 63-Year Record

Prescription drug prices are falling at the fastest annual rate since 1963 — seven straight months of deflation in a category that almost never deflates. Washington is fighting over the credit. The real question is who absorbs the cut.

Paid-members only

Markets Featured

$AMLX: Amylyx Just Won Its Phase 3. Now the Offering Changes the Math.

A 64% single-day surge on historic Phase 3 data. Then a $350 million equity raise announced the same evening. Here is what the dilution math, balance-sheet clock, and NDA calendar actually mean for the distribution of outcomes from here.

Finance Featured

Can the World's Biggest Stablecoin Stay in America?

Treasury just published the rule that decides who may issue and sell digital dollars in the US. The clock now runs to July 2028 — when offering an unlicensed stablecoin to Americans becomes a federal crime. Tether's $183 billion has 23 months to choose.

Paid-members only

Markets Featured

$XOS: The Micro-Cap That Just Won Its First Air Force Contract — and the Float Math Behind the 126% Pop

Members only

Markets Featured

10 Stocks Worth Watching This Week: Retail's Verdict on the Consumer Ahead of Jackson Hole — August 17–21, 2026

Four retail giants report, Reddit joins the S&P 500, and Wednesday's FOMC minutes reveal how close the Fed came to hiking — the 10 stocks that matter this week, with the catalyst, thesis, and risk for each.

Members only

Markets Featured

Why Can't $750 Million Keep Hollywood in Hollywood?

California doubled its film tax credit to $750 million — and Los Angeles shoot days still fell 13%. The subsidy war is no longer fought over shoots; it's fought over soundstages, and the stages are being built somewhere else.

Finance Featured

Where Does America Borrow When the Credit Cards Are Full?

US household debt just posted a rare quarterly decline — while home-equity borrowing rose for a 17th straight quarter. Locked into 3% mortgages and priced out of 20%+ credit cards, Americans are turning the house back into a credit line. Here's who collects.

Paid-members only

Markets Featured

BE: The AI Power War Has a Winner -- and the Balance Sheet Math Most Analysts Are Getting Wrong

Bloom Energy posted $1.065B in Q2 revenue -- up 166% YoY. Then NVIDIA-backed Nebius picked its fuel cells for a 300 MW AI data center. Here is the scenario math at $229 a share.

Paid-members only

Finance Featured

Berkshire Is Buying America's Frozen Housing Market

Everyone read Friday's Berkshire 13F for the Alphabet number. The real story: an $8.5 billion homebuilder takeover plus new Lennar and D.R. Horton stakes — the largest housing bet in Berkshire's history, placed at the bottom of builder confidence.

Paid-members only

Finance Featured

Argentina Is About to Make Money-Printing Illegal

On August 19, Argentina's Congress votes on banning the central bank from financing the state — the closest any country has come to outlawing its own money printer. What passage, dilution, or failure does to Argentine bonds, banks, and the peso.

Paid-members only

Finance Featured

How Gold and Bitcoin Stopped Being the Same Trade

Gold and bitcoin both peaked within months of each other and both crashed. Only one is recovering — and the difference is the identity of the marginal buyer. This week's CPI print made the divergence official.

Paid-members only

Markets Featured

CAPR: The FDA Has Eight Days to Decide — and One Analyst Just Doubled the Stock

Capricor Therapeutics surged 96% pre-market after Cantor Fitzgerald set a $28 price target on a $4 stock. Eight days from now the FDA decides. Here is what the three scenarios actually look like.

Finance Featured

Did America's Credit Card Crisis Already Happen?

12.8% of credit card balances are 90+ days late — a Great Recession number in a full-employment economy. The Fed's own researchers just explained why the scariest chart in consumer finance is measuring the past, and what the 23 million Americans inside it mean for the next consumer trade.

Paid-members only

Markets Featured

Intuitive Machines (LUNR): The $1.8 Billion Backlog at a $17 Stock

LUNR just reported Q2 revenue four times higher than a year ago, expanded its backlog to a record $1.8 billion, and embedded itself inside the Golden Dome missile defense architecture -- all while trading below 3x forward revenue. Here's what the scenario math looks like.

Paid-members only

Investing Featured

Emerging Markets Got Cheaper by Going Up

For the first time in at least two decades, emerging-market stocks trade at less than half the S&P 500's multiple — after five straight quarters of outperformance. Inside the record discount, and what actually closes it.

Finance Featured

Who Loses When Narcolepsy Gets Fixed?

The FDA just approved the first drug that treats narcolepsy at its source. The patient count is tiny; the stakes are not — Takeda's post-Vyvanse story, Jazz's $2 billion franchise, and a three-way race to turn wakefulness into a platform.

Finance Featured

Why Did Berkshire Stop Waiting for the Crash?

Berkshire Hathaway just ended a 14-quarter selling streak, drew its record cash pile down by $32 billion, and became a net buyer of stocks for the first time since 2022. The market's most famous bearish signal just flipped.